OTC Markets OTCPK - Delayed Quote USD
Clarity Pharmaceuticals Ltd (CLRPF)
At close: November 7 at 3:00 PM EST
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
Cash Flows from Used in Operating Activities Direct
-43,237.1030
-43,237.1030
-27,499.9570
-13,313.9180
Investing Cash Flow
-55,307.8300
-55,307.8300
3,151.0120
-26,713.5130
Financing Cash Flow
115,212.9780
115,212.9780
231.5840
86,927.8510
End Cash Position
47,900.6920
47,900.6920
31,213.0920
55,336.3280
Income Tax Paid Supplemental Data
80.9870
80.9870
103.2000
17.6320
Capital Expenditure
-504.0050
-504.0050
-46.5620
-213.1480
Issuance of Capital Stock
121,840.6190
121,840.6190
183.3350
92,399.0000
Repurchase of Capital Stock
-6,647.6410
-6,647.6410
-12.7500
-5,603.1490
Free Cash Flow
-43,741.1080
-43,741.1080
-27,546.5190
-13,527.0660
6/30/2022 - 8/15/2024
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
TLPPF Telix Pharmaceuticals Limited
15.25
+1.33%
RAPP Rapport Therapeutics, Inc.
26.90
+2.87%
EVAX Evaxion Biotech A/S
2.6200
0.00%
TLX.AX Telix Pharmaceuticals Limited
22.99
+0.57%
TFFP TFF Pharmaceuticals, Inc.
1.6300
-1.21%
RLFTF Relief Therapeutics Holding SA
6.62
-0.51%
ACIU AC Immune SA
3.2700
+5.83%
PCVX Vaxcyte, Inc.
102.70
-1.32%
CSL.AX CSL Limited
285.29
+0.67%
MDXG MiMedx Group, Inc.
7.44
-0.80%